Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins
暂无分享,去创建一个
[1] A. Doria,et al. Intravenous immunoglobulins control scleromyxoedema , 2002, Annals of the rheumatic diseases.
[2] A. Bridges,et al. Intravenous immune globulin: fighting antibodies with antibodies. , 2001, Journal of the American Academy of Dermatology.
[3] B. Loggini,et al. Lichen myxedematosus with systemic involvement: clinical and autopsy findings. , 2001, Journal of the American Academy of Dermatology.
[4] T. Luger,et al. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin. , 2001, Journal of the American Academy of Dermatology.
[5] A. Rebora,et al. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. , 2001, Journal of the American Academy of Dermatology.
[6] P. Souteyrand,et al. [Cutaneo-systemic papulosclerotic mucinosis (scleromyxedema): remission after extracorporeal photochemotherapy and corticoid bolus]. , 2001, Annales de dermatologie et de venereologie.
[7] I. Forgacs,et al. Scleromyxedema: response to high-dose intravenous immunoglobulin (hdIVIg). , 2000, Journal of the American Academy of Dermatology.
[8] E. Bisaccia,et al. Scleromyxedema with dermato-neuro syndrome. , 2000, Journal of the American Academy of Dermatology.
[9] S. Jablonska,et al. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis. , 1999, European journal of dermatology : EJD.
[10] J. Tschen,et al. Scleromyxedema: treatment with interferon alfa. , 1999, Journal of the American Academy of Dermatology.
[11] P. Altmeyer,et al. Successful treatment of pyoderma gangrenosum with intravenous human immunoglobulin. , 1998, Journal of the American Academy of Dermatology.
[12] M. Seishima,et al. Papular mucinosis associated with scleroderma. , 1998, European journal of dermatology : EJD.
[13] B. Guillot,et al. Papular mucinosis with rapid spontaneous regression in an HIV-infected patient. , 1998, European journal of dermatology : EJD.
[14] A. Pandya,et al. Fatal scleromyxedema: report of a case and review of the literature. , 1998, Journal of the American Academy of Dermatology.
[15] M. Boffa,et al. Spontaneous improvement of scleromyxoedema , 1995, Clinical and experimental dermatology.
[16] L. Matsuoka,et al. The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis). , 1993, Journal of the American Academy of Dermatology.
[17] D. Leung,et al. The immunoregulatory effects of IVIG in Kawasaki disease and other autoimmune diseases. , 1992, Clinical reviews in allergy.
[18] D. Lookingbill,et al. Plasmapheresis in a patient with scleromyxedema. , 1987, Archives of dermatology.
[19] N. Ratliff,et al. Scleromyxedema associated with scleroderma renal disease and acute psychosis. , 1986, Journal of the American Academy of Dermatology.
[20] 堀尾 武. Scleromyxedema. , 1969, Archives of dermatology.
[21] H. Gottron. Skleromyxdem: Eine eigenartige Erscheinungsform von Myxothesaurodermie , 1954 .
[22] H. Montgomery,et al. Lichen myxedematosus; differentiation from cutaneous myxedemas or mucoid states. , 1953, The Journal of investigative dermatology.